Anti-Amyloid Beta Antibody (Solanezumab)
Catalog No.
F1534
Anti-Amyloid Beta Antibody (Solanezumab)
Featured Products
Solanezumab is a humanized monoclonal IgG1 antibody targeting the middle domain of the amyloid-β (Aβ) peptide. Solanezumab has the potential for Alzheimer's disease research.
144.34 kDa
Dry ice
955085-14-0
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
LY2062430, m266, 10D5
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P05067
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
The purity of Anti-Amyloid Beta Antibody (Solanezumab) is 96.84%, determined by SEC-HPLC.
Amyloid Beta
Please avoid freeze-thaw cycles.